Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Current Oncology Reports
|
April 9, 2002
Adenosine triphosphate for cancer cachexia
T Declan Walsh, Nilo I Rivera
Cleveland Clinic Journal of Medicine
|
January 5, 2011
Symptom management: an important part of cancer care
Laura K Shoemaker, Bassam Estfan, Raghava Induru, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 11, 2025
A formal section of oncology nutrition: program development in a major cancer center (2012-2022)
Michele L Szafranski, Kunal C Kadakia, L Elizabeth York, et al.
JCO Oncology Practice
|
April 21, 2020
Levine Cancer Institute Approach to Pandemic Care of Patients With Cancer
Derek Raghavan, Edward S Kim, S Jean Chai, et al.
Cancer Research
|
December 15, 1988
Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals
C W Young, M P Fanucchi, T Declan Walsh, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Current Oncology Reports
|
April 9, 2002
Adenosine triphosphate for cancer cachexia
T Declan Walsh, Nilo I Rivera
Cleveland Clinic Journal of Medicine
|
January 5, 2011
Symptom management: an important part of cancer care
Laura K Shoemaker, Bassam Estfan, Raghava Induru, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 11, 2025
A formal section of oncology nutrition: program development in a major cancer center (2012-2022)
Michele L Szafranski, Kunal C Kadakia, L Elizabeth York, et al.
JCO Oncology Practice
|
April 21, 2020
Levine Cancer Institute Approach to Pandemic Care of Patients With Cancer
Derek Raghavan, Edward S Kim, S Jean Chai, et al.
Cancer Research
|
December 15, 1988
Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals
C W Young, M P Fanucchi, T Declan Walsh, et al.
Page
of 1